DK1814907T3 - Sæt af dele til designet til implementering af en antitumoral eller antiviral behandling hos et pattedyr - Google Patents

Sæt af dele til designet til implementering af en antitumoral eller antiviral behandling hos et pattedyr

Info

Publication number
DK1814907T3
DK1814907T3 DK05802308T DK05802308T DK1814907T3 DK 1814907 T3 DK1814907 T3 DK 1814907T3 DK 05802308 T DK05802308 T DK 05802308T DK 05802308 T DK05802308 T DK 05802308T DK 1814907 T3 DK1814907 T3 DK 1814907T3
Authority
DK
Denmark
Prior art keywords
antitumoral
mammal
implement
antiviral treatment
parts designed
Prior art date
Application number
DK05802308T
Other languages
English (en)
Inventor
Philippe Erbs
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of DK1814907T3 publication Critical patent/DK1814907T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
DK05802308T 2004-11-08 2005-10-26 Sæt af dele til designet til implementering af en antitumoral eller antiviral behandling hos et pattedyr DK1814907T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04360101 2004-11-08
US64659505P 2005-01-26 2005-01-26
PCT/IB2005/003435 WO2006048768A2 (en) 2004-11-08 2005-10-26 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal

Publications (1)

Publication Number Publication Date
DK1814907T3 true DK1814907T3 (da) 2009-05-18

Family

ID=35539415

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05802308T DK1814907T3 (da) 2004-11-08 2005-10-26 Sæt af dele til designet til implementering af en antitumoral eller antiviral behandling hos et pattedyr

Country Status (17)

Country Link
US (1) US8470591B2 (da)
EP (1) EP1814907B1 (da)
JP (2) JP5372374B2 (da)
KR (1) KR101134185B1 (da)
CN (1) CN101072792B (da)
AT (1) ATE421534T1 (da)
AU (1) AU2005300248B2 (da)
CA (1) CA2584681C (da)
CY (1) CY1109850T1 (da)
DE (1) DE602005012535D1 (da)
DK (1) DK1814907T3 (da)
ES (1) ES2320157T3 (da)
IL (1) IL183015A (da)
MX (1) MX2007005474A (da)
PL (1) PL1814907T3 (da)
PT (1) PT1814907E (da)
WO (1) WO2006048768A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ580463A (en) * 2007-04-14 2011-03-31 Southern Res Inst Methods for treating cancer with combination of clofarabine and radiation
US9687515B2 (en) 2007-11-19 2017-06-27 Transgene S.A. Poxviral oncolytic vectors
BR112012002628B1 (pt) 2009-08-07 2021-09-08 Transgene Sa Composição imunogênica, molécula de ácido nucleico, vetor, partícula viral infecciosa, micro-organismo transgênico, composição, usos da composição imunogênica e kit de partes
TW201221063A (en) * 2010-12-13 2012-06-01 Tai-Song Guo Enzyme-assisting yeast, enzyme dough, brewed dough and method of brewing bread, baozi, mantou, bagel and unique enzyme thereof
ES2768715T3 (es) 2014-04-10 2020-06-23 Transgene Vectores oncolíticos poxvíricos
US20190367886A1 (en) * 2016-07-13 2019-12-05 National University Corporation Tottori Tottori University Method for producing vaccinia virus expressing foreign gene
WO2018091680A1 (en) 2016-11-18 2018-05-24 Transgene Sa Cowpox-based oncolytic vectors
CA3056603A1 (en) * 2017-03-14 2018-09-20 Memorial Sloan Kettering Cancer Center Labeling, isolation, & analysis of rna from rare cell populations
CN111826393B (zh) * 2020-08-04 2022-02-08 湖南农业大学 一种同时调控水稻粒型粒重和抗性的基因及其编码蛋白的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856153A (en) * 1994-11-17 1999-01-05 Cayla Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases
US5858707A (en) * 1995-07-05 1999-01-12 Schering Corporation Purified mammalian nucleobase permeases; nucleic acids; antibodies
US6153740A (en) * 1995-07-07 2000-11-28 University Of Alberta cDNA encoding nucleoside transporter
US6749863B1 (en) * 1997-11-19 2004-06-15 Georgetown University Targeted liposome gene delivery
FR2777570A1 (fr) * 1998-04-17 1999-10-22 Transgene Sa Mutant ayant une activite phosphoribosyl transferase
US6552005B1 (en) * 1998-09-29 2003-04-22 Uab Research Foundation Molecular chemotherapy enhancement of radiotherapy
FR2794025A1 (fr) * 1999-05-25 2000-12-01 Transgene Sa Composition destinee a la mise en oeuvre d'un traitement antitumoral ou antiviral chez un mammifere

Also Published As

Publication number Publication date
US20090170795A1 (en) 2009-07-02
KR101134185B1 (ko) 2012-04-09
WO2006048768A3 (en) 2006-08-03
CN101072792B (zh) 2012-09-26
HK1107360A1 (en) 2008-04-03
EP1814907A2 (en) 2007-08-08
JP2013209415A (ja) 2013-10-10
WO2006048768A8 (en) 2007-06-14
AU2005300248A1 (en) 2006-05-11
MX2007005474A (es) 2007-07-10
CA2584681C (en) 2014-05-13
IL183015A0 (en) 2007-09-20
JP2008519024A (ja) 2008-06-05
IL183015A (en) 2012-02-29
CA2584681A1 (en) 2006-05-11
DE602005012535D1 (de) 2009-03-12
WO2006048768A2 (en) 2006-05-11
PT1814907E (pt) 2009-03-27
US8470591B2 (en) 2013-06-25
EP1814907B1 (en) 2009-01-21
AU2005300248B2 (en) 2012-04-26
ATE421534T1 (de) 2009-02-15
KR20070091614A (ko) 2007-09-11
CY1109850T1 (el) 2014-09-10
PL1814907T3 (pl) 2009-07-31
CN101072792A (zh) 2007-11-14
JP5372374B2 (ja) 2013-12-18
ES2320157T3 (es) 2009-05-19

Similar Documents

Publication Publication Date Title
IL183015A0 (en) Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal
EA200900404A1 (ru) Новые гены, родственные гену глутаминилциклазы
EP2099928A4 (en) TWO-STAGE NUCLEIC ACID AMPLIFICATION USING AN AMPLIFICATION OLIGOMER
CY1114725T1 (el) Χρηση αναστολεων πεπτιδιου του μονοπατιου μεταγωγης σηματος jnk οι οποιοι διαπερνουν τα κυτταρα για τη θεραπευτικη αγωγη διαφορων καρδιαγγειακων νοσων
EP1933852A4 (en) AMNION PREPARATIONS AND CLEANED COMPOSITIONS AND APPLICATION PROCEDURES
EP2037737A4 (en) PROTEINS, NUCLEIC ACIDS FOR THEIR CODING AND CORRESPONDING USES.
DK2204374T3 (da) Nucleosidphosphonater og analoge deraf til behandling af HPV-infektioner
NO20070866L (no) Antivirale forbindelser.
DK1583542T3 (da) Sammensætninger og fremgangsmåder til antiviral kombinationsterapi
ATE483027T1 (de) Rekombinante n-glykosylierte proteine aus prokaryontischen zellen
ECSP088262A (es) Proteínas de fusión de albúmina
NO20070263L (no) Immunostimulerende oligonukleotidmultimerer
TNSN07396A1 (en) Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
DE602007011972D1 (de) Mmendes nukleaseresistentes rna-aptamer
EP1490108A4 (en) DRAG11 GENERAL FAMILY (DRAGON)
PL372391A1 (en) Gene conferring resistance to phytophthera infestans (late-blight) in solanaceae
NO20070780L (no) Celloverflateprotein.
WO2005002511A3 (en) Recombinant antibodies and compositions and methods for making and using the same
NO20052956D0 (no) Defensinprotiner
ATE374838T1 (de) Nukleotidsequenzvariation im gen ns5a als marker
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
TW200724679A (en) Treatment of disease using an improved regulated expression system
DK1869172T3 (da) Forgrenet aminosyre-aminotransferasegen og anvendelse deraf
GB0423126D0 (en) Protein
DK1673391T3 (da) Modificeret cDNA til höje ekspressionsniveauer af faktor VIII og dens derivater